Glioblastoma is one of the most difficult cancers to treat. It attacks the brain, grows rapidly, and almost always returns after treatment.
Doctors have made progress with surgery, radiation, and chemotherapy, but long-term survival remains rare, driving scientists to search for completely new approaches.
Researchers at Oregon State University have now developed an experimental therapy that may help overcome two of the biggest obstacles in brain cancer treatment.
The study, led by Oleh Taratula, Olena Taratula, and Yoon Tae Goo, was published in the Journal of Controlled Release.
Most medicines cannot easily enter the brain because of the blood-brain barrier. This protective layer shields the brain from harmful substances but also blocks many useful drugs.
Even if medicines pass through, they often spread throughout healthy brain tissue instead of concentrating inside tumors.
The research team created microscopic lipid nanoparticles to carry mRNA into brain tumors. Messenger RNA provides cells with instructions to make specific proteins. In this study, the mRNA told cancer cells to produce PTEN, a natural tumor-suppressing protein that is frequently lost in glioblastoma.
To improve delivery, the nanoparticles were coated with mannose, a sugar that can use the same transport pathway as glucose. This allowed the particles to pass through the blood-brain barrier more efficiently. The scientists also strengthened the particles so the fragile mRNA remained protected until it reached the tumor.
The strategy took advantage of a weakness in glioblastoma cells. These cancer cells have much higher amounts of a glucose transporter called GLUT1 because they need large amounts of energy to grow. As a result, the mannose-coated nanoparticles accumulated inside tumors much more readily than in normal brain tissue.
In laboratory mice, repeated treatments restored PTEN activity, slowed tumor growth, and produced no measurable toxic effects in major organs. Most importantly, treated mice survived about 50% longer than untreated animals, suggesting the therapy successfully reached its target.
Although the findings are exciting, they represent early-stage research. Many treatments that perform well in animals do not always work in people because human tumors are more complex. Clinical trials will be necessary to determine whether the treatment is safe and effective for patients.
Review and analysis: The study is an excellent example of precision drug delivery, using the biology of brain tumors to guide treatment directly to cancer cells. Its greatest strength is solving both drug delivery and tumor targeting at the same time. The main limitation is that the work has only been tested in mice, so the benefits for human patients remain unknown until future clinical studies are completed.
If you care about cancer, please read studies about how to fight cancer with these anti-cancer superfoods ,and a berry that can prevent cancer, diabetes and obesity.
For more health information, please see recent studies about how to harness the power of anti-cancer foods and supplements, and cancer-fighting foods and recipes.
Source: Oregon State University.
